Rank | Gene Set | Z-score |
---|---|---|
1 | fatty acid elongation (GO:0030497) | 7.77954216 |
2 | * ensheathment of neurons (GO:0007272) | 7.08041022 |
3 | * axon ensheathment (GO:0008366) | 7.08041022 |
4 | * myelination (GO:0042552) | 7.00612005 |
5 | long-chain fatty acid biosynthetic process (GO:0042759) | 6.02242967 |
6 | negative regulation of neurotransmitter secretion (GO:0046929) | 5.77942842 |
7 | neutrophil activation involved in immune response (GO:0002283) | 5.77588395 |
8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.31125321 |
9 | myelin maintenance (GO:0043217) | 5.11438744 |
10 | negative regulation of neurotransmitter transport (GO:0051589) | 4.93385072 |
11 | apical protein localization (GO:0045176) | 4.75272792 |
12 | cholesterol biosynthetic process (GO:0006695) | 4.70829932 |
13 | asymmetric protein localization (GO:0008105) | 4.63841582 |
14 | glycerophospholipid catabolic process (GO:0046475) | 4.60536778 |
15 | creatine metabolic process (GO:0006600) | 4.46920667 |
16 | neutrophil activation (GO:0042119) | 4.44296700 |
17 | negative regulation of cell killing (GO:0031342) | 4.41372607 |
18 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.41372607 |
19 | adhesion of symbiont to host cell (GO:0044650) | 4.34729196 |
20 | virion attachment to host cell (GO:0019062) | 4.34729196 |
21 | presynaptic membrane organization (GO:0097090) | 4.34330435 |
22 | eye photoreceptor cell differentiation (GO:0001754) | 4.30804327 |
23 | photoreceptor cell differentiation (GO:0046530) | 4.30804327 |
24 | establishment of mitochondrion localization (GO:0051654) | 4.29468607 |
25 | presynaptic membrane assembly (GO:0097105) | 4.25150012 |
26 | regulation of collateral sprouting (GO:0048670) | 4.23051551 |
27 | negative regulation of protein localization to cell surface (GO:2000009) | 4.14873129 |
28 | substantia nigra development (GO:0021762) | 4.11791240 |
29 | sterol biosynthetic process (GO:0016126) | 4.10155269 |
30 | microglial cell activation (GO:0001774) | 4.09366771 |
31 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 4.07849270 |
32 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.93833426 |
33 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.88972075 |
34 | response to redox state (GO:0051775) | 3.83827073 |
35 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.82477635 |
36 | * oligodendrocyte differentiation (GO:0048709) | 3.81414614 |
37 | import into cell (GO:0098657) | 3.73115706 |
38 | L-amino acid import (GO:0043092) | 3.72865722 |
39 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.70210742 |
40 | cellular extravasation (GO:0045123) | 3.69431736 |
41 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.66519194 |
42 | positive regulation of action potential (GO:0045760) | 3.65782177 |
43 | isoprenoid biosynthetic process (GO:0008299) | 3.64737633 |
44 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.62730738 |
45 | peripheral nervous system axon ensheathment (GO:0032292) | 3.62259474 |
46 | myelination in peripheral nervous system (GO:0022011) | 3.62259474 |
47 | granulocyte activation (GO:0036230) | 3.59613161 |
48 | thrombin receptor signaling pathway (GO:0070493) | 3.58760151 |
49 | amyloid precursor protein metabolic process (GO:0042982) | 3.55059321 |
50 | protein palmitoylation (GO:0018345) | 3.54247894 |
51 | regulation of memory T cell differentiation (GO:0043380) | 3.53479987 |
52 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.52527153 |
53 | aggressive behavior (GO:0002118) | 3.48699096 |
54 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.45346785 |
55 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.45346785 |
56 | protein neddylation (GO:0045116) | 3.45279582 |
57 | response to lipoprotein particle (GO:0055094) | 3.42212695 |
58 | response to methylmercury (GO:0051597) | 3.40839039 |
59 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.38883614 |
60 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.38883614 |
61 | modulation by symbiont of host immune response (GO:0052553) | 3.38883614 |
62 | positive regulation by symbiont of host defense response (GO:0052509) | 3.38883614 |
63 | modulation by symbiont of host defense response (GO:0052031) | 3.38883614 |
64 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.38883614 |
65 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.37650572 |
66 | transmission of nerve impulse (GO:0019226) | 3.36406094 |
67 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.36191575 |
68 | inositol phosphate catabolic process (GO:0071545) | 3.32793210 |
69 | regulation of platelet aggregation (GO:0090330) | 3.31120333 |
70 | magnesium ion transport (GO:0015693) | 3.30140599 |
71 | negative regulation of axonogenesis (GO:0050771) | 3.27748409 |
72 | regulation of regulatory T cell differentiation (GO:0045589) | 3.27454417 |
73 | nitric oxide mediated signal transduction (GO:0007263) | 3.27047383 |
74 | adult walking behavior (GO:0007628) | 3.26229846 |
75 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.26166657 |
76 | glycosylceramide metabolic process (GO:0006677) | 3.26030337 |
77 | detection of other organism (GO:0098543) | 3.25320213 |
78 | GPI anchor biosynthetic process (GO:0006506) | 3.24796295 |
79 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.23473360 |
80 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.20381040 |
81 | adhesion of symbiont to host (GO:0044406) | 3.19931827 |
82 | membrane tubulation (GO:0097320) | 3.19652098 |
83 | macrophage activation (GO:0042116) | 3.19580478 |
84 | neutrophil mediated immunity (GO:0002446) | 3.19391340 |
85 | GPI anchor metabolic process (GO:0006505) | 3.19307735 |
86 | negative regulation of JUN kinase activity (GO:0043508) | 3.17779916 |
87 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.16943106 |
88 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.16532968 |
89 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.16181541 |
90 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.14839422 |
91 | inositol phosphate dephosphorylation (GO:0046855) | 3.14839422 |
92 | response to host immune response (GO:0052572) | 3.14312608 |
93 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.14312608 |
94 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.12837717 |
95 | limb bud formation (GO:0060174) | 3.12799119 |
96 | adaptation of signaling pathway (GO:0023058) | 3.12480766 |
97 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.10999472 |
98 | cellular response to epinephrine stimulus (GO:0071872) | 3.10542035 |
99 | neuron cell-cell adhesion (GO:0007158) | 3.10019075 |
100 | negative regulation of protein oligomerization (GO:0032460) | 3.09267701 |
101 | leukocyte aggregation (GO:0070486) | 3.08677437 |
102 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.07047067 |
103 | nucleotide transmembrane transport (GO:1901679) | 3.04975337 |
104 | response to peptidoglycan (GO:0032494) | 3.00858893 |
105 | positive regulation of mast cell activation (GO:0033005) | 2.98838661 |
106 | respiratory burst (GO:0045730) | 2.98571080 |
107 | peptidyl-cysteine modification (GO:0018198) | 2.96069733 |
108 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.95637708 |
109 | detection of bacterium (GO:0016045) | 2.92678956 |
110 | positive regulation of granulocyte differentiation (GO:0030854) | 2.92287952 |
111 | negative regulation of phagocytosis (GO:0050765) | 2.91278878 |
112 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.89434652 |
113 | nerve growth factor signaling pathway (GO:0038180) | 2.87770195 |
114 | neuronal ion channel clustering (GO:0045161) | 2.86930862 |
115 | neuron remodeling (GO:0016322) | 2.86434931 |
116 | peripheral nervous system development (GO:0007422) | 2.86150240 |
117 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.84600108 |
118 | macrophage activation involved in immune response (GO:0002281) | 2.81605026 |
119 | positive regulation of glial cell differentiation (GO:0045687) | 2.81110243 |
120 | regulation of platelet activation (GO:0010543) | 2.80665107 |
121 | detection of molecule of bacterial origin (GO:0032490) | 2.80168040 |
122 | insulin secretion (GO:0030073) | 2.79191548 |
123 | neural nucleus development (GO:0048857) | 2.78332845 |
124 | very long-chain fatty acid metabolic process (GO:0000038) | 2.77893859 |
125 | leukocyte degranulation (GO:0043299) | 2.77738217 |
126 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.77540028 |
127 | membrane assembly (GO:0071709) | 2.76893608 |
128 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 2.75843968 |
129 | detection of external biotic stimulus (GO:0098581) | 2.75454309 |
130 | response to epinephrine (GO:0071871) | 2.75096279 |
131 | neuronal action potential propagation (GO:0019227) | 2.74521765 |
132 | amyloid precursor protein catabolic process (GO:0042987) | 2.74328913 |
133 | negative regulation of axon extension (GO:0030517) | 2.74287840 |
134 | regulation of B cell apoptotic process (GO:0002902) | 2.71898024 |
135 | organ growth (GO:0035265) | 2.71777675 |
136 | Leydig cell differentiation (GO:0033327) | 2.70500077 |
137 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.70306239 |
138 | amino acid import (GO:0043090) | 2.69073611 |
139 | histamine secretion (GO:0001821) | 2.68814465 |
140 | ear development (GO:0043583) | 2.68511306 |
141 | endocrine pancreas development (GO:0031018) | 2.67991249 |
142 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.67324798 |
143 | acyl-CoA biosynthetic process (GO:0071616) | 2.67271114 |
144 | thioester biosynthetic process (GO:0035384) | 2.67271114 |
145 | cerebellar granule cell differentiation (GO:0021707) | 2.67065642 |
146 | myeloid cell activation involved in immune response (GO:0002275) | 2.65431710 |
147 | response to host (GO:0075136) | 2.64910826 |
148 | response to host defenses (GO:0052200) | 2.64910826 |
149 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.64910826 |
150 | positive regulation of B cell differentiation (GO:0045579) | 2.63954250 |
151 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.63716969 |
152 | regulation of lipoprotein metabolic process (GO:0050746) | 2.63154556 |
153 | relaxation of smooth muscle (GO:0044557) | 2.62209957 |
154 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.61975757 |
155 | Golgi to plasma membrane protein transport (GO:0043001) | 2.61458034 |
156 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.61152625 |
157 | polyol catabolic process (GO:0046174) | 2.60944902 |
158 | regulation of gamma-delta T cell activation (GO:0046643) | 2.58991492 |
159 | activated T cell proliferation (GO:0050798) | 2.58913287 |
160 | positive regulation of gliogenesis (GO:0014015) | 2.57966570 |
161 | phagosome maturation (GO:0090382) | 2.56681555 |
162 | histone H2B ubiquitination (GO:0033523) | 2.56376194 |
163 | monoamine transport (GO:0015844) | 2.56328176 |
164 | dopamine transport (GO:0015872) | 2.56263640 |
165 | protein localization to endosome (GO:0036010) | 2.55507462 |
166 | neurotransmitter catabolic process (GO:0042135) | 2.55001952 |
167 | cellular response to monoamine stimulus (GO:0071868) | 2.54895999 |
168 | cellular response to catecholamine stimulus (GO:0071870) | 2.54895999 |
169 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.53764090 |
170 | glucosamine-containing compound catabolic process (GO:1901072) | 2.53394835 |
171 | enteric nervous system development (GO:0048484) | 2.53299014 |
172 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.52861232 |
173 | response to hepatocyte growth factor (GO:0035728) | 2.51781600 |
174 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.51781600 |
175 | regulation of dopamine metabolic process (GO:0042053) | 2.51375002 |
176 | regulation of catecholamine metabolic process (GO:0042069) | 2.51375002 |
177 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.51312648 |
178 | L-serine transport (GO:0015825) | 2.50783163 |
179 | microtubule polymerization or depolymerization (GO:0031109) | 2.50701993 |
180 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.49155785 |
181 | negative regulation of B cell mediated immunity (GO:0002713) | 2.49155785 |
182 | platelet dense granule organization (GO:0060155) | 2.48969194 |
183 | regulation of B cell differentiation (GO:0045577) | 2.48537209 |
184 | maternal behavior (GO:0042711) | 2.47481761 |
185 | myeloid leukocyte mediated immunity (GO:0002444) | 2.46420280 |
186 | xenobiotic catabolic process (GO:0042178) | 2.45617111 |
187 | parental behavior (GO:0060746) | 2.45224270 |
188 | definitive hemopoiesis (GO:0060216) | 2.44287848 |
189 | regulation of hexokinase activity (GO:1903299) | 2.43514438 |
190 | regulation of glucokinase activity (GO:0033131) | 2.43514438 |
191 | regulation of mast cell activation (GO:0033003) | 2.43192247 |
192 | superoxide anion generation (GO:0042554) | 2.42913592 |
193 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.42639967 |
194 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.41537400 |
195 | megakaryocyte development (GO:0035855) | 2.41441158 |
196 | response to interleukin-15 (GO:0070672) | 2.40652433 |
197 | axon ensheathment in central nervous system (GO:0032291) | 11.5966810 |
198 | central nervous system myelination (GO:0022010) | 11.5966810 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.29693145 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.50323596 |
3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.85720625 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.73320498 |
5 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.73071063 |
6 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.65440107 |
7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.59832390 |
8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.47984691 |
9 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.37925890 |
10 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.32036319 |
11 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.28629140 |
12 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.27761043 |
13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.20046115 |
14 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.14122189 |
15 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.12426881 |
16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.11705911 |
17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.07340788 |
18 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.04057285 |
19 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.00553338 |
20 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.00553338 |
21 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.93557687 |
22 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.91650801 |
23 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.90182896 |
24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.89071237 |
25 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.87475062 |
26 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.87430740 |
27 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.87398023 |
28 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.85003514 |
29 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.84954243 |
30 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.84399072 |
31 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.83722412 |
32 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.81926594 |
33 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.79354087 |
34 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.76884190 |
35 | VDR_22108803_ChIP-Seq_LS180_Human | 1.76538476 |
36 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.74854087 |
37 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.72968148 |
38 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.72459993 |
39 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.70835702 |
40 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.70483520 |
41 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.70171664 |
42 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.69008080 |
43 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.68532252 |
44 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.68303845 |
45 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.66115517 |
46 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.65630517 |
47 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.65432190 |
48 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.64024945 |
49 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.63792809 |
50 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.63244293 |
51 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.59418874 |
52 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.58674338 |
53 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.58263943 |
54 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.57723063 |
55 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.56396686 |
56 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.53107078 |
57 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.51592114 |
58 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.51090998 |
59 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.51086958 |
60 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.50543641 |
61 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.50210195 |
62 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.50010800 |
63 | SPI1_23127762_ChIP-Seq_K562_Human | 1.48098331 |
64 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.45007060 |
65 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.43053892 |
66 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.42491371 |
67 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.40655216 |
68 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.39696650 |
69 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.38561255 |
70 | FUS_26573619_Chip-Seq_HEK293_Human | 1.37005657 |
71 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.35562202 |
72 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.35539011 |
73 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.33387489 |
74 | GATA3_26560356_Chip-Seq_TH2_Human | 1.33089604 |
75 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.30583869 |
76 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.29180132 |
77 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.29048225 |
78 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.28805942 |
79 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.27485913 |
80 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.27210166 |
81 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.27181161 |
82 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.26676681 |
83 | P300_19829295_ChIP-Seq_ESCs_Human | 1.26608420 |
84 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.24581855 |
85 | * MYB_26560356_Chip-Seq_TH2_Human | 1.24262201 |
86 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.24194466 |
87 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23283434 |
88 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.22104323 |
89 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.22067294 |
90 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18909204 |
91 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.18154604 |
92 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.18112146 |
93 | EWS_26573619_Chip-Seq_HEK293_Human | 1.17584657 |
94 | AR_25329375_ChIP-Seq_VCAP_Human | 1.17475932 |
95 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.17434009 |
96 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.16674543 |
97 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.15951108 |
98 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.15687481 |
99 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.15204942 |
100 | STAT3_23295773_ChIP-Seq_U87_Human | 1.14821611 |
101 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.14742294 |
102 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.13819730 |
103 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.12482167 |
104 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.12086915 |
105 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.10931235 |
106 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.10777238 |
107 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.09110164 |
108 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09042888 |
109 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.08888796 |
110 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.08751668 |
111 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.08293706 |
112 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.07970361 |
113 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.07970361 |
114 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.06070319 |
115 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.05872453 |
116 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.04432805 |
117 | GATA2_19941826_ChIP-Seq_K562_Human | 1.03553326 |
118 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.02993744 |
119 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.02865256 |
120 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.02851282 |
121 | TCF4_23295773_ChIP-Seq_U87_Human | 1.02214934 |
122 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.01945194 |
123 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.00862399 |
124 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00234047 |
125 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00171582 |
126 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.00117875 |
127 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99958480 |
128 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.99821635 |
129 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.99817905 |
130 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99215866 |
131 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.98736712 |
132 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.98210501 |
133 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.97989452 |
134 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97533458 |
135 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.97158550 |
136 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.97077586 |
137 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.97076095 |
138 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.97027966 |
139 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.97027966 |
140 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.96525892 |
141 | AR_20517297_ChIP-Seq_VCAP_Human | 0.96282000 |
142 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.95917372 |
143 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.95585214 |
144 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95263850 |
145 | * P300_18555785_Chip-Seq_ESCs_Mouse | 0.94438464 |
146 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.93922726 |
147 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.93619903 |
148 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.93537294 |
149 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.93107189 |
150 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.92859732 |
151 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.91824052 |
152 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.91003399 |
153 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.90661406 |
154 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.89283665 |
155 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.89113447 |
156 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.88206210 |
157 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.88193365 |
158 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.87800261 |
159 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.87662848 |
160 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.87662848 |
161 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.87401235 |
162 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.86991733 |
163 | * TBL1_22424771_ChIP-Seq_293T_Human | 0.86507470 |
164 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.86006386 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0000920_abnormal_myelination | 5.80211902 |
2 | MP0003724_increased_susceptibility_to | 4.75986564 |
3 | MP0005464_abnormal_platelet_physiology | 4.24892155 |
4 | MP0003880_abnormal_central_pattern | 3.97173972 |
5 | MP0003787_abnormal_imprinting | 3.61561732 |
6 | MP0003950_abnormal_plasma_membrane | 3.58586001 |
7 | MP0004270_analgesia | 3.55209719 |
8 | MP0003690_abnormal_glial_cell | 3.27441983 |
9 | MP0004885_abnormal_endolymph | 2.97440385 |
10 | MP0002837_dystrophic_cardiac_calcinosis | 2.88790938 |
11 | MP0001529_abnormal_vocalization | 2.74939968 |
12 | MP0003329_amyloid_beta_deposits | 2.71344564 |
13 | MP0004742_abnormal_vestibular_system | 2.64883697 |
14 | MP0001905_abnormal_dopamine_level | 2.53673969 |
15 | MP0002272_abnormal_nervous_system | 2.52494406 |
16 | MP0002132_abnormal_respiratory_system | 2.49052204 |
17 | MP0001486_abnormal_startle_reflex | 2.47205335 |
18 | MP0003634_abnormal_glial_cell | 2.46472034 |
19 | MP0003136_yellow_coat_color | 2.46388376 |
20 | MP0005171_absent_coat_pigmentation | 2.41758667 |
21 | MP0001485_abnormal_pinna_reflex | 2.40703023 |
22 | MP0001835_abnormal_antigen_presentation | 2.33928752 |
23 | MP0005084_abnormal_gallbladder_morpholo | 2.31718975 |
24 | MP0005409_darkened_coat_color | 2.22990986 |
25 | MP0008877_abnormal_DNA_methylation | 2.20910134 |
26 | MP0003283_abnormal_digestive_organ | 2.18147638 |
27 | MP0002064_seizures | 2.18146300 |
28 | MP0004142_abnormal_muscle_tone | 2.17473703 |
29 | MP0000778_abnormal_nervous_system | 2.15316417 |
30 | MP0004859_abnormal_synaptic_plasticity | 2.10026769 |
31 | MP0005451_abnormal_body_composition | 2.06825854 |
32 | MP0002693_abnormal_pancreas_physiology | 2.06160334 |
33 | MP0002909_abnormal_adrenal_gland | 2.02297992 |
34 | MP0005645_abnormal_hypothalamus_physiol | 1.98545005 |
35 | MP0002229_neurodegeneration | 1.96050978 |
36 | MP0003122_maternal_imprinting | 1.93287766 |
37 | MP0000462_abnormal_digestive_system | 1.89048114 |
38 | MP0009046_muscle_twitch | 1.88325372 |
39 | MP0003632_abnormal_nervous_system | 1.86924154 |
40 | MP0000465_gastrointestinal_hemorrhage | 1.85447413 |
41 | MP0003436_decreased_susceptibility_to | 1.84959720 |
42 | MP0002277_abnormal_respiratory_mucosa | 1.84344218 |
43 | MP0005379_endocrine/exocrine_gland_phen | 1.82956676 |
44 | MP0008004_abnormal_stomach_pH | 1.82850517 |
45 | MP0000013_abnormal_adipose_tissue | 1.82783898 |
46 | MP0005410_abnormal_fertilization | 1.77566573 |
47 | MP0003172_abnormal_lysosome_physiology | 1.74883181 |
48 | MP0002734_abnormal_mechanical_nocicepti | 1.74495453 |
49 | MP0002419_abnormal_innate_immunity | 1.71034276 |
50 | MP0010678_abnormal_skin_adnexa | 1.68839198 |
51 | MP0003303_peritoneal_inflammation | 1.68409651 |
52 | MP0009745_abnormal_behavioral_response | 1.68395160 |
53 | MP0004147_increased_porphyrin_level | 1.68030402 |
54 | MP0003635_abnormal_synaptic_transmissio | 1.67921157 |
55 | MP0010386_abnormal_urinary_bladder | 1.61977872 |
56 | MP0003011_delayed_dark_adaptation | 1.61491387 |
57 | MP0000383_abnormal_hair_follicle | 1.60323236 |
58 | MP0005646_abnormal_pituitary_gland | 1.57654365 |
59 | MP0004484_altered_response_of | 1.57253735 |
60 | MP0009785_altered_susceptibility_to | 1.54692893 |
61 | MP0005423_abnormal_somatic_nervous | 1.54189347 |
62 | MP0004381_abnormal_hair_follicle | 1.54110484 |
63 | MP0002102_abnormal_ear_morphology | 1.50540479 |
64 | MP0001944_abnormal_pancreas_morphology | 1.49884793 |
65 | MP0004043_abnormal_pH_regulation | 1.47713248 |
66 | MP0000955_abnormal_spinal_cord | 1.47289010 |
67 | MP0005000_abnormal_immune_tolerance | 1.45200935 |
68 | MP0002163_abnormal_gland_morphology | 1.44956716 |
69 | MP0005671_abnormal_response_to | 1.41061297 |
70 | MP0002254_reproductive_system_inflammat | 1.41002948 |
71 | MP0002882_abnormal_neuron_morphology | 1.39966820 |
72 | MP0005551_abnormal_eye_electrophysiolog | 1.39766169 |
73 | MP0001545_abnormal_hematopoietic_system | 1.38165934 |
74 | MP0005397_hematopoietic_system_phenotyp | 1.38165934 |
75 | MP0005025_abnormal_response_to | 1.37976404 |
76 | MP0001533_abnormal_skeleton_physiology | 1.36928332 |
77 | MP0001440_abnormal_grooming_behavior | 1.36888281 |
78 | MP0002723_abnormal_immune_serum | 1.36822672 |
79 | MP0005075_abnormal_melanosome_morpholog | 1.36346659 |
80 | MP0002420_abnormal_adaptive_immunity | 1.35866149 |
81 | MP0000685_abnormal_immune_system | 1.35697114 |
82 | MP0000604_amyloidosis | 1.35199481 |
83 | MP0001819_abnormal_immune_cell | 1.34649040 |
84 | MP0001963_abnormal_hearing_physiology | 1.30024128 |
85 | MP0003631_nervous_system_phenotype | 1.29512657 |
86 | MP0001661_extended_life_span | 1.29228100 |
87 | MP0001800_abnormal_humoral_immune | 1.28670175 |
88 | MP0005248_abnormal_Harderian_gland | 1.27990536 |
89 | MP0004134_abnormal_chest_morphology | 1.26739084 |
90 | MP0001299_abnormal_eye_distance/ | 1.26248354 |
91 | MP0002066_abnormal_motor_capabilities/c | 1.25301449 |
92 | MP0005220_abnormal_exocrine_pancreas | 1.24900797 |
93 | MP0002572_abnormal_emotion/affect_behav | 1.24847797 |
94 | MP0000230_abnormal_systemic_arterial | 1.24769362 |
95 | MP0003300_gastrointestinal_ulcer | 1.23479155 |
96 | MP0001346_abnormal_lacrimal_gland | 1.23344593 |
97 | MP0001845_abnormal_inflammatory_respons | 1.23035751 |
98 | MP0005174_abnormal_tail_pigmentation | 1.22616064 |
99 | MP0005386_behavior/neurological_phenoty | 1.21682660 |
100 | MP0004924_abnormal_behavior | 1.21682660 |
101 | MP0003866_abnormal_defecation | 1.21591136 |
102 | MP0000747_muscle_weakness | 1.21154192 |
103 | MP0003806_abnormal_nucleotide_metabolis | 1.20868459 |
104 | MP0003121_genomic_imprinting | 1.20540411 |
105 | MP0002452_abnormal_antigen_presenting | 1.20489330 |
106 | MP0008260_abnormal_autophagy | 1.19832573 |
107 | MP0002928_abnormal_bile_duct | 1.19698032 |
108 | MP0002752_abnormal_somatic_nervous | 1.18859770 |
109 | MP0002067_abnormal_sensory_capabilities | 1.15735802 |
110 | MP0008569_lethality_at_weaning | 1.15628088 |
111 | MP0005623_abnormal_meninges_morphology | 1.15561677 |
112 | MP0002148_abnormal_hypersensitivity_rea | 1.13393136 |
113 | MP0000566_synostosis | 1.12590979 |
114 | MP0002063_abnormal_learning/memory/cond | 1.12549298 |
115 | MP0001970_abnormal_pain_threshold | 1.12336001 |
116 | MP0000689_abnormal_spleen_morphology | 1.12305493 |
117 | MP0002398_abnormal_bone_marrow | 1.09846934 |
118 | MP0005367_renal/urinary_system_phenotyp | 1.09789754 |
119 | MP0000516_abnormal_urinary_system | 1.09789754 |
120 | MP0008872_abnormal_physiological_respon | 1.08640773 |
121 | MP0002078_abnormal_glucose_homeostasis | 1.08458641 |
122 | MP0005387_immune_system_phenotype | 1.06907165 |
123 | MP0001790_abnormal_immune_system | 1.06907165 |
124 | MP0003075_altered_response_to | 1.03915493 |
125 | MP0002166_altered_tumor_susceptibility | 1.03114285 |
126 | MP0001851_eye_inflammation | 1.03079048 |
127 | MP0003633_abnormal_nervous_system | 1.02875570 |
128 | MP0005535_abnormal_body_temperature | 1.02391214 |
129 | MP0001765_abnormal_ion_homeostasis | 1.02116782 |
130 | MP0000716_abnormal_immune_system | 1.01126284 |
131 | MP0000015_abnormal_ear_pigmentation | 1.00697684 |
132 | MP0003938_abnormal_ear_development | 1.00082174 |
133 | MP0002733_abnormal_thermal_nociception | 0.98388922 |
134 | MP0001756_abnormal_urination | 0.97224475 |
135 | MP0005195_abnormal_posterior_eye | 0.96380862 |
136 | MP0003656_abnormal_erythrocyte_physiolo | 0.96204849 |
137 | MP0001986_abnormal_taste_sensitivity | 0.96065158 |
138 | MP0003937_abnormal_limbs/digits/tail_de | 0.95255002 |
139 | MP0002722_abnormal_immune_system | 0.95044527 |
140 | MP0001348_abnormal_lacrimal_gland | 0.94817264 |
141 | MP0002405_respiratory_system_inflammati | 0.93841495 |
142 | MP0005058_abnormal_lysosome_morphology | 0.93411476 |
143 | MP0003195_calcinosis | 0.92959065 |
144 | MP0000647_abnormal_sebaceous_gland | 0.92714105 |
145 | MP0004145_abnormal_muscle_electrophysio | 0.92493777 |
146 | MP0001984_abnormal_olfaction | 0.92303747 |
147 | MP0005408_hypopigmentation | 0.91593905 |
148 | MP0000026_abnormal_inner_ear | 0.86443244 |
149 | MP0004883_abnormal_blood_vessel | 0.84211578 |
150 | MP0000762_abnormal_tongue_morphology | 0.83450415 |
151 | MP0002152_abnormal_brain_morphology | 0.83411774 |
152 | MP0010155_abnormal_intestine_physiology | 0.83031188 |
153 | MP0000703_abnormal_thymus_morphology | 0.82748625 |
154 | MP0002429_abnormal_blood_cell | 0.82729251 |
155 | MP0002295_abnormal_pulmonary_circulatio | 0.82726480 |
156 | MP0010329_abnormal_lipoprotein_level | 0.82679635 |
157 | MP0006072_abnormal_retinal_apoptosis | 0.81710802 |
158 | MP0004510_myositis | 0.81701681 |
159 | MP0001177_atelectasis | 0.81449668 |
160 | MP0002735_abnormal_chemical_nociception | 0.80266141 |
161 | MP0008469_abnormal_protein_level | 0.80032544 |
162 | MP0006036_abnormal_mitochondrial_physio | 0.79421084 |
163 | MP0009642_abnormal_blood_homeostasis | 0.79386110 |
164 | MP0001727_abnormal_embryo_implantation | 0.79236297 |
165 | MP0003828_pulmonary_edema | 0.78025108 |
166 | MP0000467_abnormal_esophagus_morphology | 0.76127558 |
167 | MP0009764_decreased_sensitivity_to | 0.75587070 |
168 | MP0005636_abnormal_mineral_homeostasis | 0.73468279 |
169 | MP0009780_abnormal_chondrocyte_physiolo | 0.73252734 |
170 | MP0001968_abnormal_touch/_nociception | 0.73108285 |
171 | MP0008438_abnormal_cutaneous_collagen | 0.72090814 |
172 | MP0003943_abnormal_hepatobiliary_system | 0.71094083 |
173 | MP0005253_abnormal_eye_physiology | 0.70304097 |
174 | MP0003191_abnormal_cellular_cholesterol | 0.69977508 |
175 | MP0004808_abnormal_hematopoietic_stem | 0.69508048 |
176 | MP0004185_abnormal_adipocyte_glucose | 0.68784638 |
177 | MP0004036_abnormal_muscle_relaxation | 0.68673595 |
178 | MP0003137_abnormal_impulse_conducting | 0.66543937 |
179 | MP0004133_heterotaxia | 0.66353373 |
180 | MP0002184_abnormal_innervation | 0.65819735 |
181 | MP0001501_abnormal_sleep_pattern | 0.65652724 |
182 | MP0001502_abnormal_circadian_rhythm | 0.62854054 |
183 | MP0006082_CNS_inflammation | 0.61624188 |
184 | MP0002090_abnormal_vision | 0.60872121 |
185 | MP0002736_abnormal_nociception_after | 0.59662239 |
186 | MP0002133_abnormal_respiratory_system | 0.58459397 |
187 | MP0005388_respiratory_system_phenotype | 0.58459397 |
188 | MP0000579_abnormal_nail_morphology | 0.57506989 |
189 | MP0002557_abnormal_social/conspecific_i | 0.55180479 |
190 | MP0001340_abnormal_eyelid_morphology | 0.54617403 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 6.84400761 |
2 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 6.84400761 |
3 | Neurofibrillary tangles (HP:0002185) | 6.32331806 |
4 | Prolonged bleeding time (HP:0003010) | 6.14429437 |
5 | Sensory axonal neuropathy (HP:0003390) | 5.50623768 |
6 | Petechiae (HP:0000967) | 5.07914834 |
7 | Parakeratosis (HP:0001036) | 5.06229012 |
8 | Abnormality of the corticospinal tract (HP:0002492) | 5.04053231 |
9 | Stomatitis (HP:0010280) | 4.96353235 |
10 | Cerebral inclusion bodies (HP:0100314) | 4.48205170 |
11 | Peripheral hypomyelination (HP:0007182) | 4.44829445 |
12 | Gingival bleeding (HP:0000225) | 4.17316944 |
13 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.92612766 |
14 | Menorrhagia (HP:0000132) | 3.81969638 |
15 | Cerebral hypomyelination (HP:0006808) | 3.78595451 |
16 | Spastic gait (HP:0002064) | 3.77601804 |
17 | Abnormal platelet volume (HP:0011876) | 3.76520004 |
18 | Epistaxis (HP:0000421) | 3.74762539 |
19 | Supranuclear gaze palsy (HP:0000605) | 3.71387496 |
20 | Onion bulb formation (HP:0003383) | 3.63341846 |
21 | Increased mean platelet volume (HP:0011877) | 3.52945421 |
22 | Myositis (HP:0100614) | 3.49768048 |
23 | Recurrent abscess formation (HP:0002722) | 3.49755228 |
24 | Intention tremor (HP:0002080) | 3.36189756 |
25 | Akinesia (HP:0002304) | 3.34990663 |
26 | Recurrent bacterial skin infections (HP:0005406) | 3.34775610 |
27 | Hypoglycemic coma (HP:0001325) | 3.31200629 |
28 | Alacrima (HP:0000522) | 3.31147834 |
29 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.31128032 |
30 | Abnormal auditory evoked potentials (HP:0006958) | 3.29876471 |
31 | Eczematoid dermatitis (HP:0000976) | 3.27969950 |
32 | Hypoglycemic seizures (HP:0002173) | 3.25913660 |
33 | Dysmetria (HP:0001310) | 3.19878403 |
34 | Episodic fever (HP:0001954) | 3.19229593 |
35 | Retrobulbar optic neuritis (HP:0100654) | 3.16301344 |
36 | Optic neuritis (HP:0100653) | 3.16301344 |
37 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.13023458 |
38 | Insidious onset (HP:0003587) | 3.07832513 |
39 | Termporal pattern (HP:0011008) | 3.07832513 |
40 | Abnormal pupillary function (HP:0007686) | 3.06283450 |
41 | Abnormality of macrophages (HP:0004311) | 3.06099821 |
42 | Orchitis (HP:0100796) | 3.05924387 |
43 | Purpura (HP:0000979) | 3.05497103 |
44 | Hypochromic microcytic anemia (HP:0004840) | 2.95723890 |
45 | Thickened helices (HP:0000391) | 2.91299497 |
46 | Spontaneous hematomas (HP:0007420) | 2.88433800 |
47 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.88247191 |
48 | Encephalitis (HP:0002383) | 2.87018904 |
49 | Leukodystrophy (HP:0002415) | 2.86285427 |
50 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.85644135 |
51 | Abnormality of glycolysis (HP:0004366) | 2.83798600 |
52 | Increased serum pyruvate (HP:0003542) | 2.83798600 |
53 | Scanning speech (HP:0002168) | 2.82272311 |
54 | Slow saccadic eye movements (HP:0000514) | 2.81830393 |
55 | Autoamputation (HP:0001218) | 2.80946601 |
56 | Myokymia (HP:0002411) | 2.80490739 |
57 | Hyperlipoproteinemia (HP:0010980) | 2.80314706 |
58 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.78340693 |
59 | Hematochezia (HP:0002573) | 2.76225659 |
60 | Hyperglycemia (HP:0003074) | 2.75696895 |
61 | Anteriorly placed anus (HP:0001545) | 2.73768039 |
62 | Spastic paraparesis (HP:0002313) | 2.73321267 |
63 | Hypothermia (HP:0002045) | 2.72419517 |
64 | Ketoacidosis (HP:0001993) | 2.71422962 |
65 | Retinal dysplasia (HP:0007973) | 2.70285808 |
66 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.69647364 |
67 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.68153134 |
68 | Premature skin wrinkling (HP:0100678) | 2.65858648 |
69 | Hypoplastic pelvis (HP:0008839) | 2.62943646 |
70 | Ankle clonus (HP:0011448) | 2.61935939 |
71 | Panhypogammaglobulinemia (HP:0003139) | 2.58678993 |
72 | Decreased lacrimation (HP:0000633) | 2.57888603 |
73 | Stridor (HP:0010307) | 2.57323743 |
74 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.56593909 |
75 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.56593909 |
76 | Cerebral hemorrhage (HP:0001342) | 2.55595551 |
77 | Absent septum pellucidum (HP:0001331) | 2.51842269 |
78 | Recurrent fungal infections (HP:0002841) | 2.47025274 |
79 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.43800534 |
80 | Recurrent cutaneous fungal infections (HP:0011370) | 2.43800534 |
81 | Increased circulating renin level (HP:0000848) | 2.40133538 |
82 | Split foot (HP:0001839) | 2.35066012 |
83 | CNS hypomyelination (HP:0003429) | 2.34100636 |
84 | Clumsiness (HP:0002312) | 2.34076152 |
85 | Recurrent skin infections (HP:0001581) | 2.31962548 |
86 | Coronal craniosynostosis (HP:0004440) | 2.28023127 |
87 | Arterial thrombosis (HP:0004420) | 2.24808186 |
88 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.23604820 |
89 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.22051889 |
90 | Pheochromocytoma (HP:0002666) | 2.20812727 |
91 | Infantile muscular hypotonia (HP:0008947) | 2.20549768 |
92 | Morphological abnormality of the inner ear (HP:0011390) | 2.19351727 |
93 | Hypomagnesemia (HP:0002917) | 2.18638108 |
94 | Obstructive lung disease (HP:0006536) | 2.17431724 |
95 | Chronic obstructive pulmonary disease (HP:0006510) | 2.17431724 |
96 | Hepatosplenomegaly (HP:0001433) | 2.17385085 |
97 | Thyroiditis (HP:0100646) | 2.17170833 |
98 | Keratoconjunctivitis (HP:0001096) | 2.14832727 |
99 | Abnormality of the septum pellucidum (HP:0007375) | 2.13594363 |
100 | T lymphocytopenia (HP:0005403) | 2.13104979 |
101 | Partial agenesis of the corpus callosum (HP:0001338) | 2.11735834 |
102 | Lower limb muscle weakness (HP:0007340) | 2.11443416 |
103 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.11387733 |
104 | Cupped ear (HP:0000378) | 2.10434194 |
105 | Metabolic alkalosis (HP:0200114) | 2.10018061 |
106 | Humeroradial synostosis (HP:0003041) | 2.09838884 |
107 | Synostosis involving the elbow (HP:0003938) | 2.09838884 |
108 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.09525991 |
109 | Muscle fibrillation (HP:0010546) | 2.09249649 |
110 | Stomach cancer (HP:0012126) | 2.09211071 |
111 | Intestinal atresia (HP:0011100) | 2.08875775 |
112 | Decreased central vision (HP:0007663) | 2.08410329 |
113 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.05724005 |
114 | Spastic tetraparesis (HP:0001285) | 2.05200057 |
115 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.04600097 |
116 | Megalencephaly (HP:0001355) | 2.04103785 |
117 | Agitation (HP:0000713) | 2.04009860 |
118 | Abnormality of T cell number (HP:0011839) | 2.03862894 |
119 | Keratoconjunctivitis sicca (HP:0001097) | 2.02679485 |
120 | Leukocytosis (HP:0001974) | 2.02655201 |
121 | Methylmalonic acidemia (HP:0002912) | 2.01768659 |
122 | Increased density of long bones (HP:0006392) | 2.01386267 |
123 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.01345040 |
124 | Hypokalemic alkalosis (HP:0001949) | 1.98530367 |
125 | Muscle fiber splitting (HP:0003555) | 1.97930543 |
126 | Renal Fanconi syndrome (HP:0001994) | 1.97536121 |
127 | White forelock (HP:0002211) | 1.97363953 |
128 | Adrenal hypoplasia (HP:0000835) | 1.97093263 |
129 | Progressive neurologic deterioration (HP:0002344) | 1.96312787 |
130 | Facial diplegia (HP:0001349) | 1.96242163 |
131 | Increased CSF protein (HP:0002922) | 1.96159742 |
132 | Patchy hypopigmentation of hair (HP:0011365) | 1.95992302 |
133 | Poor speech (HP:0002465) | 1.95581668 |
134 | Chest pain (HP:0100749) | 1.95576010 |
135 | Foot dorsiflexor weakness (HP:0009027) | 1.94952483 |
136 | Aplasia involving bones of the extremities (HP:0009825) | 1.94425090 |
137 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.94425090 |
138 | Aplasia of the phalanges of the hand (HP:0009802) | 1.94425090 |
139 | Microcytic anemia (HP:0001935) | 1.94258300 |
140 | Absent/shortened dynein arms (HP:0200106) | 1.92603824 |
141 | Neuroendocrine neoplasm (HP:0100634) | 1.92183918 |
142 | Atonic seizures (HP:0010819) | 1.89711305 |
143 | Bowel incontinence (HP:0002607) | 1.88662026 |
144 | Alveolar cell carcinoma (HP:0006519) | 1.88435762 |
145 | Partial duplication of thumb phalanx (HP:0009944) | 1.88231240 |
146 | Hypoplasia of the iris (HP:0007676) | 1.88185568 |
147 | Barrel-shaped chest (HP:0001552) | 1.87193208 |
148 | Erythroderma (HP:0001019) | 1.86644174 |
149 | Gastrointestinal infarctions (HP:0005244) | 1.85791908 |
150 | Testicular neoplasm (HP:0010788) | 1.85786454 |
151 | Symptomatic seizures (HP:0011145) | 1.84669063 |
152 | Urinary incontinence (HP:0000020) | 1.84283743 |
153 | Paraparesis (HP:0002385) | 1.81576052 |
154 | Clonus (HP:0002169) | 1.81011246 |
155 | Diminished movement (HP:0002374) | 1.81006411 |
156 | Decreased motor nerve conduction velocity (HP:0003431) | 1.80876130 |
157 | Anorexia (HP:0002039) | 1.80149060 |
158 | Generalized myoclonic seizures (HP:0002123) | 1.79180439 |
159 | Ketosis (HP:0001946) | 1.78976672 |
160 | Anomalous pulmonary venous return (HP:0010772) | 1.78625515 |
161 | Gowers sign (HP:0003391) | 1.78550128 |
162 | Acute hepatic failure (HP:0006554) | 1.78280264 |
163 | Hyporeflexia of lower limbs (HP:0002600) | 1.77865470 |
164 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.77636507 |
165 | Vaginal atresia (HP:0000148) | 1.77408736 |
166 | Medial flaring of the eyebrow (HP:0010747) | 1.77347654 |
167 | Meningitis (HP:0001287) | 1.77067733 |
168 | Abnormality of T cells (HP:0002843) | 1.76928821 |
169 | Bruising susceptibility (HP:0000978) | 1.76610206 |
170 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.75311561 |
171 | Abnormal large intestine physiology (HP:0012700) | 1.75256998 |
172 | Abnormality of the foot musculature (HP:0001436) | 1.74862778 |
173 | Pulmonary embolism (HP:0002204) | 1.74381651 |
174 | Palpitations (HP:0001962) | 1.73598144 |
175 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.72654747 |
176 | Menstrual irregularities (HP:0000858) | 1.72213736 |
177 | Abnormality of T cell physiology (HP:0011840) | 1.71945860 |
178 | Polydipsia (HP:0001959) | 1.70770300 |
179 | Abnormal drinking behavior (HP:0030082) | 1.70770300 |
180 | Esophageal atresia (HP:0002032) | 1.70325399 |
181 | Constricted visual fields (HP:0001133) | 1.69683707 |
182 | Dyschromatopsia (HP:0007641) | 1.69615428 |
183 | Chronic otitis media (HP:0000389) | 1.69150745 |
184 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.68855686 |
185 | Relative macrocephaly (HP:0004482) | 1.68782593 |
186 | Joint swelling (HP:0001386) | 1.68708190 |
187 | Abnormal ciliary motility (HP:0012262) | 1.67822846 |
188 | Disproportionate short-trunk short stature (HP:0003521) | 1.67213282 |
189 | 3-Methylglutaconic aciduria (HP:0003535) | 1.67076054 |
190 | Abnormality of the renal cortex (HP:0011035) | 1.67009581 |
191 | Papilledema (HP:0001085) | 1.66947833 |
192 | Genital tract atresia (HP:0001827) | 1.66763381 |
193 | Abolished electroretinogram (ERG) (HP:0000550) | 1.66241778 |
194 | Renal cortical cysts (HP:0000803) | 1.66222739 |
195 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.65670720 |
196 | Abnormal hair whorl (HP:0010721) | 1.65283557 |
Rank | Gene Set | Z-score |
---|---|---|
1 | STK39 | 6.59393400 |
2 | FRK | 4.98857201 |
3 | OXSR1 | 4.85655695 |
4 | EPHB1 | 3.07809547 |
5 | BCR | 3.03018351 |
6 | RIPK4 | 2.92297807 |
7 | CDK19 | 2.83408925 |
8 | TNIK | 2.66902692 |
9 | WNK4 | 2.65192957 |
10 | PKN1 | 2.48297993 |
11 | MET | 2.37691294 |
12 | PBK | 2.22704839 |
13 | LIMK1 | 2.12658104 |
14 | WNK1 | 2.10903756 |
15 | TEC | 2.07935774 |
16 | FGFR2 | 2.07263697 |
17 | TAOK1 | 2.06110085 |
18 | WNK3 | 2.03062413 |
19 | ICK | 2.02100506 |
20 | TAOK3 | 2.00379394 |
21 | CSNK1G3 | 1.94438121 |
22 | BTK | 1.94211702 |
23 | MAP2K3 | 1.93472118 |
24 | GRK6 | 1.91757162 |
25 | YES1 | 1.90561281 |
26 | CSNK1A1L | 1.88406336 |
27 | NEK6 | 1.87471350 |
28 | PRPF4B | 1.83739503 |
29 | TNK2 | 1.79200959 |
30 | DAPK2 | 1.77718283 |
31 | PNCK | 1.75915181 |
32 | MAPKAPK5 | 1.74950480 |
33 | UHMK1 | 1.72942571 |
34 | MYLK | 1.71233489 |
35 | NTRK1 | 1.62354588 |
36 | EPHA3 | 1.58042261 |
37 | IRAK4 | 1.53888122 |
38 | ROCK2 | 1.52607803 |
39 | CAMK2B | 1.51737679 |
40 | CSNK1G1 | 1.50928636 |
41 | MAP2K6 | 1.49777586 |
42 | NLK | 1.49210814 |
43 | BLK | 1.45784908 |
44 | CLK1 | 1.45376941 |
45 | CSNK1G2 | 1.45090995 |
46 | SYK | 1.42391425 |
47 | PAK6 | 1.39699834 |
48 | FGR | 1.38955075 |
49 | EPHA4 | 1.30754887 |
50 | STK24 | 1.28148437 |
51 | CAMK2D | 1.26217402 |
52 | PIK3CG | 1.25536033 |
53 | MST4 | 1.25390907 |
54 | HCK | 1.23504622 |
55 | PINK1 | 1.22310426 |
56 | NUAK1 | 1.21123173 |
57 | MAP4K1 | 1.20268991 |
58 | ZAP70 | 1.16617428 |
59 | TXK | 1.14153674 |
60 | GRK1 | 1.12602849 |
61 | TESK2 | 1.10473928 |
62 | ERBB3 | 1.09091196 |
63 | LYN | 1.07815416 |
64 | EIF2AK1 | 1.07018439 |
65 | MAP3K4 | 1.03458399 |
66 | CASK | 1.01573910 |
67 | CSF1R | 1.01133545 |
68 | FGFR3 | 1.00668142 |
69 | MAP3K5 | 0.99124642 |
70 | PAK3 | 0.96070246 |
71 | MAP2K4 | 0.95665769 |
72 | CAMK2G | 0.95093238 |
73 | MAP3K12 | 0.94713077 |
74 | SGK494 | 0.93165995 |
75 | SGK223 | 0.93165995 |
76 | MAPK15 | 0.91792801 |
77 | CDK14 | 0.91283045 |
78 | STK3 | 0.90340201 |
79 | TYRO3 | 0.90220246 |
80 | MARK1 | 0.90201194 |
81 | IKBKE | 0.88451950 |
82 | PLK2 | 0.86635944 |
83 | PRKCQ | 0.86321410 |
84 | LCK | 0.84736437 |
85 | JAK2 | 0.83466976 |
86 | TYK2 | 0.83207968 |
87 | ARAF | 0.82815982 |
88 | CDK5 | 0.81123401 |
89 | JAK1 | 0.80728831 |
90 | PASK | 0.80412992 |
91 | DYRK2 | 0.79840946 |
92 | ERBB4 | 0.79282997 |
93 | CDK15 | 0.78049192 |
94 | MARK2 | 0.77238297 |
95 | ACVR1B | 0.76390801 |
96 | CAMK2A | 0.75391896 |
97 | TRPM7 | 0.75286502 |
98 | JAK3 | 0.75065984 |
99 | MAP3K3 | 0.74211273 |
100 | BMPR2 | 0.73242281 |
101 | BMPR1B | 0.73150729 |
102 | CDK18 | 0.72824137 |
103 | STK4 | 0.70362717 |
104 | CDK11A | 0.70235747 |
105 | MUSK | 0.69312952 |
106 | SGK2 | 0.69001364 |
107 | MAP3K1 | 0.68841413 |
108 | MAP3K13 | 0.66160128 |
109 | MAP4K2 | 0.65354031 |
110 | STK38L | 0.64808796 |
111 | IRAK2 | 0.64726163 |
112 | PRKD1 | 0.63370181 |
113 | IKBKB | 0.63058733 |
114 | GRK5 | 0.62899255 |
115 | ADRBK1 | 0.62730558 |
116 | PDPK1 | 0.60839513 |
117 | FER | 0.60158075 |
118 | INSRR | 0.59790237 |
119 | FYN | 0.58732157 |
120 | MAP3K6 | 0.58181612 |
121 | BMX | 0.57917806 |
122 | PRKCE | 0.57730585 |
123 | KSR2 | 0.54131019 |
124 | KIT | 0.54006517 |
125 | NTRK3 | 0.52586261 |
126 | PHKG2 | 0.51537317 |
127 | PHKG1 | 0.51537317 |
128 | DYRK3 | 0.51275234 |
129 | CSNK1D | 0.49909846 |
130 | PRKG1 | 0.45513269 |
131 | STK11 | 0.45077852 |
132 | FLT3 | 0.44650897 |
133 | PRKCH | 0.44039835 |
134 | RPS6KA5 | 0.42693518 |
135 | ITK | 0.41226194 |
136 | TRIM28 | 0.41113604 |
137 | MATK | 0.40704834 |
138 | CSNK1A1 | 0.39320894 |
139 | IRAK1 | 0.37772109 |
140 | MAP2K2 | 0.37451556 |
141 | DYRK1B | 0.36675683 |
142 | CAMK1G | 0.35772749 |
143 | PRKACB | 0.35606323 |
144 | PAK1 | 0.34895980 |
145 | PIK3CA | 0.34311440 |
146 | MAPK7 | 0.33512040 |
147 | GSK3A | 0.32641698 |
148 | NTRK2 | 0.31910795 |
149 | STK16 | 0.30962062 |
150 | PDGFRB | 0.30907271 |
151 | MAP3K2 | 0.30301229 |
152 | MAPK13 | 0.29341610 |
153 | ADRBK2 | 0.29169610 |
154 | OBSCN | 0.28491397 |
155 | HIPK2 | 0.28209868 |
156 | FES | 0.28127591 |
157 | MELK | 0.27511688 |
158 | ROCK1 | 0.26840275 |
159 | INSR | 0.26654379 |
160 | PDK1 | 0.26266600 |
161 | PRKACA | 0.25038427 |
162 | MAPK10 | 0.23786611 |
163 | DMPK | 0.23685047 |
164 | MAP3K9 | 0.22819629 |
165 | PTK2B | 0.22612718 |
166 | DDR2 | 0.22513210 |
167 | CSK | 0.21797696 |
168 | GRK7 | 0.21241957 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 5.25826274 |
2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 5.19055646 |
3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.58792751 |
4 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.32196840 |
5 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.49686239 |
6 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 3.18067285 |
7 | Ether lipid metabolism_Homo sapiens_hsa00565 | 3.10574987 |
8 | Platelet activation_Homo sapiens_hsa04611 | 2.93932884 |
9 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.27792067 |
10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.24726947 |
11 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.24096988 |
12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.21342618 |
13 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.16022708 |
14 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.13630527 |
15 | Protein export_Homo sapiens_hsa03060 | 2.11900336 |
16 | Axon guidance_Homo sapiens_hsa04360 | 1.99526392 |
17 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.97825668 |
18 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.78339354 |
19 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.66406419 |
20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.60564332 |
21 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.56762144 |
22 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.52333231 |
23 | Leishmaniasis_Homo sapiens_hsa05140 | 1.51454589 |
24 | Parkinsons disease_Homo sapiens_hsa05012 | 1.48817740 |
25 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.46525240 |
26 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.46112044 |
27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.45478482 |
28 | Alzheimers disease_Homo sapiens_hsa05010 | 1.44931211 |
29 | Legionellosis_Homo sapiens_hsa05134 | 1.44136409 |
30 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.43131347 |
31 | Insulin secretion_Homo sapiens_hsa04911 | 1.42093274 |
32 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.40286228 |
33 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.35798089 |
34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.32853316 |
35 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.32353323 |
36 | GABAergic synapse_Homo sapiens_hsa04727 | 1.27318777 |
37 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.25786410 |
38 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.23928651 |
39 | Tuberculosis_Homo sapiens_hsa05152 | 1.23903595 |
40 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.22902737 |
41 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.22241466 |
42 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.20961192 |
43 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.19266085 |
44 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.08765137 |
45 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.08135209 |
46 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.07183890 |
47 | Tight junction_Homo sapiens_hsa04530 | 1.04825477 |
48 | Long-term depression_Homo sapiens_hsa04730 | 1.03155450 |
49 | Morphine addiction_Homo sapiens_hsa05032 | 1.02728937 |
50 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.02716563 |
51 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.97882818 |
52 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.96434416 |
53 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.94849670 |
54 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.90159088 |
55 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.89959632 |
56 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.87668027 |
57 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.85404299 |
58 | Endocytosis_Homo sapiens_hsa04144 | 0.84693336 |
59 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.84537517 |
60 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.83884859 |
61 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.82235908 |
62 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.81670749 |
63 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.81232182 |
64 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.80796533 |
65 | Measles_Homo sapiens_hsa05162 | 0.80705787 |
66 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.76525691 |
67 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.75668010 |
68 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.74949756 |
69 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.74567479 |
70 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.74520652 |
71 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.74155493 |
72 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.74121836 |
73 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.73720480 |
74 | Cocaine addiction_Homo sapiens_hsa05030 | 0.73659442 |
75 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.73145912 |
76 | Huntingtons disease_Homo sapiens_hsa05016 | 0.72742015 |
77 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.69948506 |
78 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.68950113 |
79 | Phototransduction_Homo sapiens_hsa04744 | 0.68377617 |
80 | Lysosome_Homo sapiens_hsa04142 | 0.67557509 |
81 | Circadian entrainment_Homo sapiens_hsa04713 | 0.66783204 |
82 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.66144753 |
83 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.65761239 |
84 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.65411865 |
85 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.65360227 |
86 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.65271390 |
87 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.63662977 |
88 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.63258575 |
89 | Olfactory transduction_Homo sapiens_hsa04740 | 0.62874689 |
90 | Nicotine addiction_Homo sapiens_hsa05033 | 0.62696301 |
91 | Salivary secretion_Homo sapiens_hsa04970 | 0.62487694 |
92 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.62064668 |
93 | Shigellosis_Homo sapiens_hsa05131 | 0.61974655 |
94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61064011 |
95 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.60767158 |
96 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.59474284 |
97 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.59235925 |
98 | Malaria_Homo sapiens_hsa05144 | 0.58802296 |
99 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.57640569 |
100 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.57029161 |
101 | Allograft rejection_Homo sapiens_hsa05330 | 0.56469351 |
102 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.55899996 |
103 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.55151591 |
104 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54947932 |
105 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.54922792 |
106 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.54307039 |
107 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.53485956 |
108 | Phagosome_Homo sapiens_hsa04145 | 0.52339070 |
109 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.51209891 |
110 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.51181570 |
111 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51054261 |
112 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.50867794 |
113 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.50458960 |
114 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.50028866 |
115 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.48910577 |
116 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.48722504 |
117 | Mineral absorption_Homo sapiens_hsa04978 | 0.47507741 |
118 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.47336989 |
119 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.47263897 |
120 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.46586089 |
121 | Insulin resistance_Homo sapiens_hsa04931 | 0.45247714 |
122 | Peroxisome_Homo sapiens_hsa04146 | 0.44120205 |
123 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.44045954 |
124 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.43941237 |
125 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.42739307 |
126 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.40824810 |
127 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.40733825 |
128 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40517940 |
129 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.40063832 |
130 | Taste transduction_Homo sapiens_hsa04742 | 0.36520016 |
131 | Gap junction_Homo sapiens_hsa04540 | 0.35492119 |
132 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.35293181 |
133 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.35196944 |
134 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.34127685 |
135 | Renin secretion_Homo sapiens_hsa04924 | 0.33757945 |
136 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.30969919 |
137 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.30648267 |
138 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.30332490 |
139 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.27904520 |
140 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.27782655 |
141 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.27536420 |
142 | Alcoholism_Homo sapiens_hsa05034 | 0.26951705 |
143 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.26688990 |
144 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.25850392 |
145 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.24328378 |
146 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.23828054 |
147 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.21382397 |